Literature DB >> 8524534

Hysteroscopy and assisted reproductive technology.

J P Balmaceda1, I Ciuffardi.   

Abstract

Hysteroscopy is an excellent additional instrument for evaluating the uterine characteristics in infertile women. This article reviews the two main indications for hysteroscopy in infertile patients who are candidates for assisted reproductive techniques: (1) to evaluate the cervix and uterine cavity and (2) rule out any pathology or lesions that could have been missed by hysterosalpingography. Hysteroscopy has been proposed as an alternative method to traditional transabdominal transfer of gamete or embryo to the tube.

Entities:  

Mesh:

Year:  1995        PMID: 8524534

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  5 in total

1.  Office hysteroscopy for infertility: a series of 557 consecutive cases.

Authors:  Martin Koskas; Jean-Luc Mergui; Chadi Yazbeck; Serge Uzan; Jacky Nizard
Journal:  Obstet Gynecol Int       Date:  2010-04-14

2.  Diagnostic hysteroscopy - a retrospective study of 1545 cases.

Authors:  Andreea Stefanescu; Bogdan Marinescu
Journal:  Maedica (Buchar)       Date:  2012-12

3.  Hysteroscopic findings in patients with a history of two implantation failures following in vitro fertilization.

Authors:  Ashraf Moini; Kiandokht Kiani; Firouzeh Ghaffari; Fatemeh Hosseini
Journal:  Int J Fertil Steril       Date:  2012-06-19

4.  A multi-centre randomised controlled study of pre-IVF outpatient hysteroscopy in women with recurrent IVF implantation failure: Trial of Outpatient Hysteroscopy - [TROPHY] in IVF.

Authors:  Tarek El-Toukhy; Rudi Campo; Sesh Kamal Sunkara; Yacoub Khalaf; Arri Coomarasamy
Journal:  Reprod Health       Date:  2009-12-03       Impact factor: 3.223

5.  Hysteroscopic cervical features associated with difficult embryo transfer in unselected patients undergoing in vitro fertilization.

Authors:  Yu-Che Ou; Kuan-Hui Huang; Kuo-Chung Lan
Journal:  Biomed J       Date:  2021-07-05       Impact factor: 7.892

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.